📈 Stocks
—
📉 Bearish
BioNTech Shares Slip 1.2% as BMO Capital Downgrades Stock to Market Perform
(28 minutes ago)
BioNTech faces pressure as BMO Capital downgrades the stock, citing lower COVID-19 vaccine demand and reduced 2026 revenue guidance, while the company…